Pac Premier
Giving Guide
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen shares slip after projections of flat 2021 sales

By   /   Friday, February 5th, 2021  /   Comments Off on Amgen shares slip after projections of flat 2021 sales

    Print       Email
Amgen saw rising revenue in the fourth quarter of 2020, but the COVID-19 pandemic could dampen the outlook for the company and its investors in 2021, according to earnings released Feb. 2. The Thousand Oaks-based company, one of the world’s largest biotech firms and the biggest publicly traded company in the tri-county region, had $6.6…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Limoneira, Calavo both report earnings growth as produce industry continues recovery

Read More →